dianova

DianovaLogo_grey

Dianova holds an exclusive licence from the German Cancer Research Center (DKFZ, Heidelberg, Germany) to produce and worldwide distribute the anti-IDH1 R132H clone H09. This highly specific antibody was developed for robust FFPE staining on brain tumor specimen by Prof. Dr. Andreas von Deimling, Department of Neuropathology, University Heidelberg / Clinical Cooperation Unit Neuropathology, German Cancer Research Center.

Dianova GmbH
Warburgstr. 45
20354 Hamburg
Germany

main website: www.dianova.de
email: info@dianova.de
phone: +49 40 45067 0
fax: +49 40 45067 490